MM

Michael Mike Harsh

Mr Harsh is a co-founder and Chief Product Officer of Terapede Systems, a digital X-ray startup that focuses on developing an ultra-high resolution medical flat panel X-ray detector. Prior to co-founding Terapede Systems in 2015, Mr. Harsh had a 36-year long career with General Electric, including serving as Global Technology Leader - Imaging Technologies at the GE Global Research Center and culminating with him serving as Vice President and Chief Technology of GE Healthcare. Additionally, he serves on the boards of directors of Endra Life Sciences (NASDAQ: NDRA), EmOpti Inc. and Compute Health Acquisition Corp (NYSE:CPUH). He had previously served as a director for FloDesign Sonics until its acquisition by MilliporeSigma, a division of the Merck Group. He holds U.S. patents in the field of medical imaging and instrumentation. He is member of risk committee. Former directorships (last 3 years) include NociMed (2019-2020).

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IBX
IBX
22/08/246,500N/A12,500N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IBX
IBX
28/04/23
Expiry
60,000$0.015$900As advised by the company
IBX
IBX
06/08/20
Issued
500,000$0.058$29,000Issue of options
IBX
IBX
23/06/20
Issued
50,000$0.033$1,650Conversion of securities
IBX
IBX
23/06/20
Exercise
50,000$0.033$1,650Conversion of securities
IBX
IBX
28/04/20
Issued
60,000$0.010$600Rights issue